We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Open Access Site Shares Microbial Genome Data

By LabMedica International staff writers
Posted on 24 Nov 2008
Whole genome sequences of the microbes Escherichia coli, Staphylococcus aureus, and Rhodobacter sphaeroides were released in sample datasets on an open-access website. More...


The bacteria were sequenced with consensus accuracies greater than 99.995%. Each sample dataset, containing between six and 12 million aligned reads, was generated from one channel of a 50-channel run on the HeliScope Single Molecule Sequencer.

The open access site for sharing data sets and bioinformatics software tools is called the HeliSphere Technology Center. It was launched by Helicos BioSciences Corporation (Cambridge, MA, USA) during the 58th annual meeting of the American Society of Human Genetics. The meeting took place in Philadelphia (PA, USA) on November 13-15, 2008.

Data from a number of sequencing projects currently underway will be posted on the HeliSphere Technology Center Web site on a regular basis. In addition to Helicos data sets, the new Web site is also a gateway to Helicos' open source project, which includes downloadable source code and software documentation.

"The open access site benefits customers and software developers, as well as the wider scientific community by making not only datasets, but source code and support tools easily accessible," commented Helicos CEO Steve Lombardi.

Helicos BioSciences is a life science company focused on genetic analysis technologies for the diagnostic, research, and drug discovery markets. Helicos' proprietary True Single Molecule Sequencing (tSMS) technology allows direct measurement of billions of strands of DNA, enabling scientists to perform experiments and ask questions that were not possible in the past.

Related Links:
HeliSphere Technology Center
Helicos BioSciences Corporation




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.